← Back to Search

Behavioural Intervention

rTMS Treatment for Schizophrenia

Phase 2 & 3
Waitlist Available
Led By Gary Chaimowitz, MD, FRCPC
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-treatment to post treatment over 6 weeks
Awards & highlights

Study Summary

This study will examine the effects of rTMS on the negative and positive symptoms of schizophrenia using 2 treatments in sequence applied to related brain areas.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-treatment to post treatment over 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from pre-treatment to post treatment over 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Positive and Negative Symptom Scale (PANSS)
Secondary outcome measures
Mental Depression
Hamilton Depression Rating Scale (HAM-D)

Trial Design

1Treatment groups
Experimental Treatment
Group I: rTMS TreatmentExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
rTMS
2016
Completed Phase 3
~840

Find a Location

Who is running the clinical trial?

St. Joseph's Healthcare HamiltonLead Sponsor
196 Previous Clinical Trials
25,524 Total Patients Enrolled
2 Trials studying Schizophrenia
113 Patients Enrolled for Schizophrenia
Gary Chaimowitz, MD, FRCPCPrincipal InvestigatorSt. Joseph's Healthcare Hamilton
1 Previous Clinical Trials
10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
rTMS Treatment for Positive and Negative Symptoms of Schizophrenia
Gary Chaimowitz 2016. "rTMS Treatment for Positive and Negative Symptoms of Schizophrenia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03413527.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top